Related Experiment Video
Updated: May 11, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Pathogenesis of membranous nephropathy: a new paradigm in evolution
1Glassock@cox.net
Abstract:
Membranous nephropathy (MN) has been recognized as a distinct morphological entity for over 50 years, but it is only recently that the underlying pathogenesis of the primary form of the disorder has been elucidated. This brief overview catalogues recent advances in understanding the pathogenesis of MN, focused mainly on its primary form. These studies have enumerated and identified several autologous podocyte antigens that serve as targets of autoantibody responses in primary MN. The dominant autoantigen is M-type phospholipase A2 receptor protein (PLA2R1) expressed on the surface of native glomerular podocytes. Autoantibodies to PLA2R1, usually of IgG4 subclass, are found in about 80% of patients with primary MN. These autoantibodies bind to genetically determined, conformational epitopes on PLA2R1, form immune complexes in situ and induce proteinuria, mostly likely via local activation of complement via the mannose-binding lectin pathway. The autoimmune response is modulated by genes at the HLA-DQA1 locus. The level of autoantibody to PLA2R correlates with the severity of the clinical disease and may predict recurrences in renal allografts, at least in some patients. Most forms of secondary MN appear to be due to distinctly different pathogenetic mechanisms.
Insights
Recent research clarifies the cause of primary membranous nephropathy (MN). Autoantibodies targeting the phospholipase A2 receptor (PLA2R) on podocytes are key drivers of this kidney disease.
Area of Science:
- Nephrology
- Immunology
- Pathogenesis of Kidney Diseases
Background:
- Membranous nephropathy (MN) is a kidney disease with a known morphology but recently elucidated primary pathogenesis.
- Primary MN involves an autoimmune response targeting podocyte antigens.
Purpose of the Study:
- To review recent advances in understanding the pathogenesis of primary MN.
- To identify key autoantigens and mechanisms involved in primary MN.
Main Methods:
- Identification of autologous podocyte antigens targeted by autoantibodies.
- Analysis of autoantibody characteristics (e.g., subclass, target epitopes).
- Investigation of genetic modulation (e.g., HLA-DQA1) and complement pathway involvement.
Main Results:
- The M-type phospholipase A2 receptor (PLA2R) is the dominant autoantigen in primary MN.
- Approximately 80% of primary MN patients have IgG4 autoantibodies against PLA2R.
- Immune complex formation and complement activation (MBL pathway) contribute to proteinuria.
- HLA-DQA1 locus influences the autoimmune response.
- PLA2R autoantibody levels correlate with disease severity and may predict graft recurrence.
Conclusions:
- Primary MN is largely driven by autoantibodies to PLA2R on podocytes.
- The pathogenesis involves specific autoantigens, genetic factors, and complement activation.
- Secondary MN forms likely have different underlying mechanisms.
Related Concept Videos
Nephrotic Syndrome I : Introduction
Diabetic Nephropathy
Viral Mutations
Acute Kidney Injury II: Pathophysiology
Evolution of New Traits in Microbes
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

